Lymph node examination should be expanded to accurately assess cancer spread in patients with lung cancer
Reports and Proceedings
Updates every hour. Last Updated: 11-Jun-2026 13:15 ET (11-Jun-2026 17:15 GMT/UTC)
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to accurately identify cancer spread.
Researchers at Brown University Health have identified a key molecular mechanism that may improve treatment for glioblastoma, one of the most aggressive forms of adult brain cancer. In a study published November 10 in Cell Reports, the team found that differences among cells within a single tumor play a major role in chemotherapy resistance and uncovered a small molecule, miR-181d, that helps regulate this variability. By stabilizing miR-181d levels, researchers were able to make tumor cells respond more uniformly to chemotherapy, potentially increasing its effectiveness. The discovery has already led to the development of a promising new gene-therapy–based approach aimed at improving outcomes for patients with glioblastoma.
A study led by the Medical University of South Carolina (MUSC) Global Surgery Program, in partnership with George Regional Hospital in South Africa, reported that a traveling mobile endoscopy team performed more than 500 procedures across five rural hospitals in South Africa’s Western Cape.
A new analysis led by UC Berkeley, published today in JAMA Health Forum, shows that the passage of "red flag" laws — also called extreme risk protection orders — does reduce suicides by gun. The researchers looked at data from four states that passed ERPO laws and eight that did not, and concluded that the laws reduced firearm suicides by a mean of 3.79 incidences per 100,000 population, with an estimated 675 suicides prevented across these four states between the year the law was passed and following year. Non-firearm suicide rates did not change.